CGRP Forum is made possible thanks to support from AbbVie and Pfizer, all of whom have no influence or control over editorial content. More information is available here »

Anti-CGRP therapy and cluster headache: Where are we now?Patients report migraine improvement with eptinezumab after previous anti-CGRP prevention failure Importance of counselling in CGRP mAb discussions with patients of childbearing potential LUNA data show atogepant benefits in menstrual migraine New US migraine guidelines recommend anti-CGRP therapies for migraine prevention Topline BEOND studies support abobotulinumtoxinA in migraine Reassuring persistence rates with CGRP mAb therapy in adolescents and adults ECLIPSE analyses show consistent atogepant effects across multiple migraine attacks

Educational Partners and Supporters

CGRP Education and Research Forum is made possible thanks to support from industry leaders, all of whom have no influence or control over editorial content.

	This program is funded in part via an independent educational grant from AbbVie.
	Financial support was provided from Pfizer Inc as an independent grant. Pfizer have provided only financial support and have had no input into the content provided.

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie.

Financial support was provided from Pfizer Inc as an independent grant. Pfizer have provided only financial support and have had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

© 2026 | Privacy Policy | Editorial Policy | Governance | Disclaimer Statement | Partnership & Outreach | Educational Partners and Supporters |